Clinical Trial Update: The Antidepressant Efficacy of the Anticholinergic Scopolamine [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluated the antidepressant efficacy of scopolamine in unipolar and bipolar depression. The study was terminated and results were posted in 201…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder
• Major Depressive Disorder

Drugs mentioned

• SCOPOLAMINE (SCOPOLAMINE)

Snippet

Sponsor: National Institute of Mental Health (NIMH) | Conditions: Unipolar Depression, Bipolar Depression | Phase 2 | Status: TERMINATED | Results posted: 2016-04-29